Herein, we report a novel TOR1AIP2::ETV6 transcript that was predicted to express no fusion protein in a patient with AML that progressed from MDS with the FLT3-ITD mutation. This evidence concerns the gene TOR1AIP2 and myelodysplastic syndrome.